Cancer-startup Hiloprobe partner up with team of investors and angels

Hiloprobe  AB has signed off on a partnership deal with a group of public and private stakeholders who have come together to back this high-potential startup. Hiloprobe is now complemented with much needed business expertise – as Mattias Pettersson from Northern Light Capital joins the board of directors, The company aims to launch their product for improved colorectal cancer diagnosis by 2020.

Read more

Annual investment event yielded five investor leads per startup

The ninth edition of Biotech Umeå’s annual partnering event was the first ever to fill up before deadline. Around 30 Swedish and European investors met with 13 startups and early cases. Two weeks after the event participants report an impressive turnout – on average they have retained at least five active leads per company.

Read more

High quality line-up great value for both sides at BUID2017

The eight consecutive Biotech Umeå Investment Day attracted almost 30 Swedish and international investors to Blasierummet at Grand Hotel on the 2 of February 2017 in Stockholm. One of the most appreciated aspects of the event was the flexibility to arrange additional ad-hoc partnering meetings and the size and atmosphere at the event.

Read more